PARP1, an extensively studied target for cancer therapy, plays a pivotal role in the DNA damage response by covalently transferring ADP-ribose from NAD+ to target substrates, producing poly (ADP-ribose) (PAR) polymers. The gene discussed is PARP1; the disease is cancer.